Kindred Biosciences Announces First Quarter 2014 Financial Results and Completion of Enrollment in CereKin Pivotal Study

[PR Newswire] – SAN FRANCISCO, May 12, 2014 /PRNewswire/ — Kindred Biosciences, Inc. (NASDAQ: KIN) today announced financial results for the quarter ended March 31, 2014. In addition, Kindred Bio announced that it has … more

View todays social media effects on KIN

View the latest stocks trending across Twitter. Click to view dashboard

See who Kindred is hiring next, click here to view